Literature DB >> 3872129

Patterns of antihistone antibody specificity in systemic rheumatic disease. I Systemic lupus erythematosus, mixed connective tissue disease, primary sicca syndrome, and rheumatoid arthritis with vasculitis.

R M Bernstein, R N Hobbs, D J Lea, D J Ward, G R Hughes.   

Abstract

A new fluorimetric assay was used to measure the relative amounts of antibodies to individual nuclear histones in sera from 102 patients with systemic lupus erythematosus (SLE), mixed connective tissue disease, primary sicca syndrome, and rheumatoid arthritis with vasculitis. In SLE sera, the predominant responses were to histones H-1, H-2B, and H-3, with marked elevations of binding to H-1 and H-2B in one-third of the patients, and to H-3 in one-fourth; antibodies of both the IgG and IgM classes were also detected. In a few SLE sera, the pattern of histone response differed or was restricted to 1 immunoglobulin class. In mixed connective tissue disease, only 2 of 9 sera showed elevated histone binding activity, the response being predominantly to H-3 in 1 patient and to H-1 and H-2B in the other. Binding to H-2B was also prominent in 2 of 3 patients with primary sicca syndrome. The highest antihistone reactivity and the most heterogeneous response patterns were observed in patients who had rheumatoid arthritis with vasculitis; 6 of 8 of those sera had elevated histone reactivity. In SLE, the highest histone binding results were found among patients with a history of photosensitivity. Histones are closely associated with DNA in the nucleosome, and we speculate that antihistone antibodies could arise as a result of damage to DNA, induced by drugs or irradiation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3872129     DOI: 10.1002/art.1780280308

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  19 in total

Review 1.  Juvenile chronic arthritis, chronic iridocyclitis, and reactivity to histones.

Authors:  A M Leak; P Woo
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

Review 2.  Clinical relevance of autoantibodies in systemic rheumatic diseases.

Authors:  M J Fritzler
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

3.  Anti-H1 histone antibodies in systemic lupus erythematosus: epitope localization after immunoblotting of chymotrypsin-digested H1.

Authors:  O Costa; J C Tchouatcha-Tchouassom; B Roux; J C Monier
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

4.  Immunoglobulin G subclass distribution of autoantibodies in systemic sclerosis, primary biliary cirrhosis, and overlap syndromes.

Authors:  M A French; R M Bernstein
Journal:  Ann Rheum Dis       Date:  1987-06       Impact factor: 19.103

5.  Evidence for direct anti-heparin-sulphate reactivity in sera of SLE patients.

Authors:  K Pirner; A Rascu; W Nürnberg; A Rubbert; J R Kalden; B Manger
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

6.  Individual variation in the isotype profile of anti-histone autoantibodies in systemic lupus erythematosus.

Authors:  G Fellows; N Gittoes; D G Scott; J S Coppock; A Wainwright; M Goodall; B M Turner
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

7.  Anti-histone antibodies (ELISA and immunoblot) in canine lupus erythematosus.

Authors:  A Brinet; C Fournel; J R Faure; C Venet; J C Monier
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

8.  Relationship of age and sex to autoantibody expression in MRL-+/+ and MRL-lpr/lpr mice: demonstration of an association between the expression of antibodies to histones, denatured DNA and Sm in MRL-+/+ mice.

Authors:  M G Cohen; K M Pollard; L Schrieber
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

9.  Antibodies to histones in systemic lupus erythematosus: prevalence, specificity, and relationship to clinical and laboratory features.

Authors:  M G Cohen; K M Pollard; J Webb
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

10.  A monoclonal antibody to the surface membrane of human platelets which inhibits ristocetin- and collagen-induced platelet aggregation reacts with H1 histones of cell nuclei.

Authors:  L Cosgrove; F Alderuccio; B H Toh; J Pedersen; A Holliday; I McKenzie
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.